ArticleFrontiers in nutrition2026
Elevated remnant cholesterol is linked to non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study was to investigate the association between remnant cholesterol (RC) levels and non-alcoholic fatty liver disease (NAFLD) in patients diagnosed with type 2 diabetes mellitus (T2DM). Participants and methods: This was a cross-sectional study involving 308 patients with T2DM who were hospitalized at Hebei General Hospital. The participants were categorized into a NAFLD group and a non-NAFLD (control) group, and comparative analyses were conducted between the groups. Regression analysis, subgroup analysis, and interaction tests were performed. Additionally, restricted cubic spline (RCS), predicted probability, and sensitivity analyses were used to explore and verify the association between RC levels and NAFLD. Results: Elevated RC levels were associated with NAFLD (OR = 4.23, 95% CI: 1.73-12.04) after adjusting for all confounding factors, regardless of whether RC was treated as a continuous or tertile variable. No significant interactions were observed for any of the subgroups, including age ( Conclusion: In patients with T2DM, RC levels are independently associated with NAFLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.